drugset / Trial / NCT04849065
Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Phase 2
Unknown
100 enrolled
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
RandomizedParallel-groupDouble-blindTreatment
Summary
Our working hypothesis is that the injection of autologous bone marrow mononuclear cells (BMNC) has a positive effect on the natural loss of motor units and on the increase in the size of the motor unit that occurs in patients with ALS during the evolution of the disease
Timeline
- Start
- 2021-05-01
- Primary completion
- 2023-05-01
- Completion
- 2023-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MNC (Mononuclear cells) | Unknown | — | Intramuscular |